You are here: Industry Insights > Market News > Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

expresspharmaApril 30, 2021

Tag: Covaxin , Bharat Biotech , Serum Institute of India

Favorites

Bharat Biotech has slashed the price of its COVID-19 vaccine Covaxin for state governments from ₹600 to ₹400 per dose, the company said in a statement. The price of Covaxin for private healthcare providers is ₹1,200 per dose.

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

The announcement came one day after the Serum Institute of India, reduced the price of Covishield from ₹400 to ₹300.

“Bharat Biotech is deeply concerned with the critical pandemic circumstances that India is facing at this time. Recognising the enormous challenges to the public health care system, we have made Covaxin available to state governments at a price of ₹ 400 per dose,” the company said in a statement.

Previous:Pfizer Acquires Amplyx Pharmaceuticals

Next:Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may like
More>>

Covaxin prices slashed from Rs 600 to Rs 400 per dose for states

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>